245 related articles for article (PubMed ID: 1695804)
21. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
Aalto ML; Selkäinaho K; Collan Y
Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
[TBL] [Abstract][Full Text] [Related]
22. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
[TBL] [Abstract][Full Text] [Related]
23. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
Liu MP; Lu ZT; Chen W
Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
[TBL] [Abstract][Full Text] [Related]
24. [Serum level of the tumor marker CA 125 in ovarian pathology].
Bagni B; Pansini FS; Feggi LM; Prandini N; Mollica G
Radiol Med; 1987 Nov; 74(5):448-50. PubMed ID: 3479814
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical demonstration of epithelial membrane antigen (EMA), carcinoembryonic antigen (CEA), and keratin on mammary and extramammary Paget's disease.
Mori O; Hachisuka H; Sasai Y
Acta Histochem; 1989; 85(1):93-100. PubMed ID: 2469278
[TBL] [Abstract][Full Text] [Related]
26. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
Devaney K; Goodman ZD; Ishak KG
Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
[TBL] [Abstract][Full Text] [Related]
27. Serous tumor of low malignant potential with early stromal invasion (serous LMP with microinvasion).
Tavassoli FA
Mod Pathol; 1988 Nov; 1(6):407-14. PubMed ID: 2464824
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas.
Ryuko K; Iwanari O; Kitao M; Moriwaki S
Gynecol Oncol; 1993 May; 49(2):215-24. PubMed ID: 8504990
[TBL] [Abstract][Full Text] [Related]
29. Malignant ascites of serous papillary ovarian adenocarcinoma. An immunocytochemical study of the tumor cells.
Guzman J; Hilgarth M; Bross KJ; Ross A; Wiehle U; Kresin V; Grunert F; von Kleist S
Acta Cytol; 1988; 32(4):519-22. PubMed ID: 3041721
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
31. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
Koelbl H; Schieder K; Neunteufel W; Bieglmayer C
Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933
[TBL] [Abstract][Full Text] [Related]
32. B-cell antigen marker expression in nasopharyngeal carcinoma.
Zhong XY; Senba M; Gu JN; Itakura H
Zentralbl Pathol; 1993 Nov; 139(4-5):281-6. PubMed ID: 7510513
[TBL] [Abstract][Full Text] [Related]
33. Synovial sarcoma. An immunohistochemical study of the epithelial component.
Jørgensen LJ; Lyon H; Myhre-Jensen O; Nordentoft A; Sneppen O
APMIS; 1994 Mar; 102(3):191-6. PubMed ID: 7514419
[TBL] [Abstract][Full Text] [Related]
34. Changes in expression of differentiation markers between normal ovarian cells and derived tumors.
Van Niekerk CC; Ramaekers FC; Hanselaar AG; Aldeweireldt J; Poels LG
Am J Pathol; 1993 Jan; 142(1):157-77. PubMed ID: 7678716
[TBL] [Abstract][Full Text] [Related]
35. Tumor markers in the human ovary and its neoplasms. A comparative immunohistochemical study.
Nouwen EJ; Hendrix PG; Dauwe S; Eerdekens MW; De Broe ME
Am J Pathol; 1987 Feb; 126(2):230-42. PubMed ID: 3548400
[TBL] [Abstract][Full Text] [Related]
36. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
[TBL] [Abstract][Full Text] [Related]
37. Ovarian tumors of low malignant potential (borderline tumors): immune morphology and current status.
Neunteufel W; Gitsch G; Schieder K; Kölbl H; Breitenecker G
Anticancer Res; 1989; 9(4):993-7. PubMed ID: 2684001
[TBL] [Abstract][Full Text] [Related]
38. Epithelial cell markers and proliferating cells in odontogenic jaw cysts.
Matthews JB; Mason GI; Browne RM
J Pathol; 1988 Dec; 156(4):283-90. PubMed ID: 2465398
[TBL] [Abstract][Full Text] [Related]
39. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer].
Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y
Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692
[TBL] [Abstract][Full Text] [Related]
40. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
